---
title: "002038.SZ (002038.SZ) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/002038.SZ/news.md"
symbol: "002038.SZ"
name: "002038.SZ"
parent: "https://longbridge.com/zh-HK/quote/002038.SZ.md"
datetime: "2026-03-12T01:16:19.088Z"
locales:
  - [en](https://longbridge.com/en/quote/002038.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002038.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002038.SZ/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/002038.SZ/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/002038.SZ/news.md)


# 002038.SZ (002038.SZ) — 相關新聞

### [Intraday News - Shuanghong (3324) surged 7.27%, reported at 959 yuan](https://longbridge.com/zh-HK/news/278473099.md)
*2026-03-10T01:40:46.000Z*
> The stock price of Shuanghong (3324-TW) rose by 65 TWD at 09:40 on the 10th, reaching 959.0 TWD, an increase of 7.27%, w

### [Investigation into SL PHARM's performance reversal: Stock trading may not have exploded, but there are clouds of doubt surrounding financial disclosure data! The Secretary of the Board implemented unusual reductions in the fourth quarter of last year](https://longbridge.com/zh-HK/news/275723255.md)
*2026-02-12T08:13:13.000Z*
> SL PHARM has attracted attention due to issues related to wealth management and stock trading, with an expected net loss

### [Expected loss of nearly 300 million yuan! SL PHARM's investment "flops," chairman personally pays 50 million yuan to fill the gap](https://longbridge.com/zh-HK/news/275292873.md)
*2026-02-09T09:04:06.000Z*
> SL PHARM expects a net profit loss of 290 million to 200 million yuan in 2025, a significant decrease compared to the pr

### [Due to the impact of "stock speculation," SL PHARM's expected loss amount sets a company record](https://longbridge.com/zh-HK/news/274834433.md)
*2026-02-04T14:38:17.000Z*
> SL PHARM expects a net loss of 200 million to 290 million yuan in 2025, a significant decline of 170.03%-291.54% year-on

### [What to do if the company's investment loses 200 million? The chairman promises to first cover 50 million](https://longbridge.com/zh-HK/news/274775574.md)
*2026-02-04T07:39:04.000Z*
> SL PHARM expects a net loss of 200 million to 290 million yuan in 2025, mainly due to investment and financial managemen

### [SL PHARM: The main business of its subsidiary Ouning Pharmacy is drug sales, and it currently does not hold shares in pharmaceutical distribution enterprises](https://longbridge.com/zh-HK/news/274615339.md)
*2026-02-03T07:27:35.000Z*
> On February 3rd, SL PHARM stated on the interactive platform that its subsidiary Ouning Pharmacy primarily engages in dr

### [National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance](https://longbridge.com/zh-HK/news/274372521.md)
*2026-01-31T02:39:00.000Z*
> On January 31, according to the National Healthcare Security Administration, the new national medical insurance drug lis

### [During the flu season, these listed companies are reducing product prices](https://longbridge.com/zh-HK/news/269364184.md)
*2025-12-11T10:06:10.000Z*
> The flu season has led to an increase in demand for related drugs and vaccines, resulting in price reductions for produc

### [SL PHARM: The current number of orders for Oseltamivir has increased](https://longbridge.com/zh-HK/news/268166332.md)
*2025-12-02T01:21:26.000Z*
> SL PHARM stated on the interactive platform that this national centralized procurement is for Oseltamivir granules, whil

### [SL PHARM: Nitroglycerin spray is the company's exclusive formulation variety, and the company is increasing its promotional efforts](https://longbridge.com/zh-HK/news/267666208.md)
*2025-11-27T09:55:51.000Z*
> SL PHARM stated that nitroglycerin spray is its exclusive formulation, which has advantages such as convenience of use,